Cetuximab in head and neck cancer

被引：1
作者：
Parikh, P. M. [1 ]
Bhattacharyya, G. S. [2 ]
Vora, A. [3 ]
机构：
[1] Indian Cooperat Oncol Network, Mumbai, Maharashtra, India
[2] AMRI, Dept Med Oncol, Kolkata, India
[3] Max Hosp, New Delhi, India
来源：
INDIAN JOURNAL OF CANCER | 2011年 / 48卷 / 02期
关键词：
SQUAMOUS-CELL CARCINOMA; PLUS CETUXIMAB; RADIOTHERAPY; CHEMOTHERAPY; CHEMORADIOTHERAPY;
D O I：
10.4103/0019-509X.82871
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：145 / 147
页数：3
相关论文
共 16 条
[1]   Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice? [J].
Agarwal, J. P. ;
Gupta, T. ;
Kalyani, N. ;
Budrukkar, A. ;
Laskar, S. G. ;
Murthy, V ;
Kumar, P. ;
Narohna, V ;
Pai, P. ;
Chaturvedi, P. ;
D'cruz, A. K. .
INDIAN JOURNAL OF CANCER, 2011, 48 (02) :148-153
[2]   Cetuximab - A review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer [J].
Blick, Stephanie K. A. ;
Scott, Lesley J. .
DRUGS, 2007, 67 (17) :2585-2607
[3]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[4]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[5]   Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model [J].
Bozec, A. ;
Sudaka, A. ;
Fischel, J-L ;
Brunstein, M-C ;
Etienne-Grimaldi, M-C ;
Milano, G. .
BRITISH JOURNAL OF CANCER, 2008, 99 (01) :93-99
[6]   A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck [J].
Budach, W ;
Hehr, T ;
Budach, V ;
Belka, C ;
Dietz, K .
BMC CANCER, 2006, 6 (1)
[7]  
DABKARA D, 2011, P ANN C AM HEAD NECK, P43
[8]   Cetuximab plus radiotherapy in patients with unresectable locally advanced squamous cell carcinoma of head and neck region - A open labelled single arm phase II study [J].
Dattatreya, S. ;
Goswami, C. .
INDIAN JOURNAL OF CANCER, 2011, 48 (02) :154-157
[9]   Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor [J].
Goel, Arun Kumar ;
Singh, Dinesh .
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2009, 30 (03) :92-94
[10]   Concurrent Cetuximab With Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck A Single Institution Matched Case-Control Study [J].
Heron, Dwight E. ;
Rwigema, Jean-Claude M. ;
Gibson, Michael K. ;
Burton, Steven A. ;
Quinn, Annette E. ;
Ferris, Robert L. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02) :165-172
12